TONIX PHARMACEUTICALS HOLDING CORP. — Net Income by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/12c73f19-28ff-4e60-a0f4-8aaf45e81c49/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-124.0M | 2025-01-01 – 2025-12-31 | evidence 0001999371-26-005730 |
| FY 2024 | $-130.0M | 2024-01-01 – 2024-12-31 | evidence 0001999371-25-002786 |
| FY 2023 | $-116.7M | 2023-01-01 – 2023-12-31 | evidence 0001999371-24-004297 |
| FY 2022 | $-110.2M | 2022-01-01 – 2022-12-31 | evidence 0001387131-23-003377 |
| FY 2021 | $-92.3M | 2021-01-01 – 2021-12-31 | evidence 0001387131-22-003640 |
| FY 2020 | $-50.5M | 2020-01-01 – 2020-12-31 | evidence 0001387131-21-003550 |
| FY 2019 | $-28.6M | 2019-01-01 – 2019-12-31 | evidence 0001387131-20-003189 |
| FY 2018 | $-26.1M | 2018-01-01 – 2018-12-31 | evidence 0001387131-19-002012 |
| FY 2017 | $-21.1M | 2017-01-01 – 2017-12-31 | evidence 0001615774-18-001762 |
| FY 2016 | $-38.8M | 2016-01-01 – 2016-12-31 | evidence 0001615774-17-001665 |
| FY 2015 | $-48.1M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-085821 |
| FY 2014 | $-27.6M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-012769 |
| FY 2013 | $-31.9M | 2007-06-07 – 2014-03-31 | evidence 0001144204-14-030020 |
| FY 2012 | $-17.8M | 2007-06-07 – 2013-03-31 | evidence 0001144204-13-026856 |
| FY 2011 | $-8.4M | 2007-06-07 – 2012-03-31 | evidence 0001144204-12-029432 |
| FY 2010 | $-2.0M | 2010-01-01 – 2010-12-31 | evidence 0001144204-14-018823 |
| FY 2009 | $-221.0k | 2009-01-01 – 2009-12-31 | evidence 0001144204-14-018823 |
| FY 2008 | $-202.0k | 2008-01-01 – 2008-12-31 | evidence 0001144204-14-018823 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TONIX PHARMACEUTICALS HOLDING CORP. — all facts · Revenue · Operating Income